CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
SHENZHEN, Oct 30, 2025 – […]
JAKARTA, Nov 3, 2025 – ( […]
HONG KONG, Nov 3, 2025 – […]
HONG KONG, Nov 3, 2025 – […]
HONG KONG, Nov 3, 2025 – […]